Business
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
VENLO, Netherlands & REDWOOD CITY, Calif., May 19, 2026--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced at the 2026 BIO-IT World Conference & Expo in Boston that the QIAGEN Digital Insights bioinformatics business and its curated knowledge bases and bioinformatics expertise will be integrating NVIDIA accelerated computing and the NVIDIA BioNeMo platform to help researchers use AI more effectively in drug discovery.
About this update from Qiagen N.v.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":242,"height":204,"url":"https://media.zenfs.com/en/business-wire.com/466576dc7ef95fa726ea8b1a807d24ad"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/kKLrsYFNwxRZysuViXwVIA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTM1NA--/https://media.zenfs.com/en/business-wire.com/466576dc7ef95fa726ea8b1a807d24ad","width":242,"height":204},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/kKLrsYFNwxRZysuViXwVIA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTM1NA--/https://media.zenfs.com/en/business-wire.com/466576dc7ef95fa726ea8b1a807d24ad","width":242,"height":204}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases","length":150,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Goal to advance how disease mechanisms, therapeutic targets and biomarkers are identified","length":89,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Graph-based AI approach designed to help researchers explore mechanisms, therapeutic targets and biomarkers with greater speed, context and confidence","length":150,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Initial pilot programs available to select pharmaceutical and biotechnology partners, with broader availability in future stages following validation","length":149,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":538,"olType":false},{"type":"text","content":"VENLO, Netherlands & REDWOOD CITY, Calif., May 19, 2026--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced at the 2026 BIO-IT World Conference & Expo in Boston that the QIAGEN Digital Insights bioinformatics business and its curated knowledge bases and bioinformatics expertise will be integrating NVIDIA accelerated computing and the NVIDIA BioNeMo platform to help researchers use AI more effectively in drug discovery.","length":457,"tagName":"p"},{"type":"text","content":"The integration is designed to help pharmaceutical and biotechnology researchers better understand disease biology, identify promising therapeutic targets and uncover biomarkers that can suppo...